Swiftly Meds Private Limited

Revomax 2.25 mg (Piperacillin + Tazobactam) - Description and Information:

Generic Name: Piperacillin and Tazobactam
Brand Name: Revomax (This is a brand name for the combination of Piperacillin and Tazobactam)
Formulation: Injectable or IV infusion (Note: Revomax is typically available as an injectable form in hospitals and clinics, not usually as a tablet)
Strength: 2.25 mg (This refers to the combination of 2 grams of Piperacillin and 0.25 grams of Tazobactam)

Revomax is a combination antibiotic that contains Piperacillin (a penicillin-type antibiotic) and Tazobactam (a beta-lactamase inhibitor). This combination works together to treat a wide range of bacterial infections.

• Piperacillin is an antibiotic that belongs to the penicillin class. It works by inhibiting bacterial cell wall synthesis, which results in the death of the bacteria.

• Tazobactam is a beta-lactamase inhibitor. It prevents bacteria from breaking down piperacillin, thus enhancing its effectiveness against bacteria that produce beta-lactamase enzymes, which can make them resistant to penicillin-type antibiotics.

Revomax is used for treating infections caused by susceptible bacteria, particularly when other antibiotics may not be effective. It is commonly used for:

• Pneumonia (including hospital-acquired and ventilator-associated pneumonia)

• Urinary tract infections (UTIs)

• Intra-abdominal infections (e.g., peritonitis, appendicitis)

• Skin and soft tissue infections

• Bloodstream infections (bacteremia)

• Gynecological infections, such as pelvic inflammatory disease

• Sepsis caused by Gram-negative or Gram-positive bacteria

• Post-surgical infections and for prophylaxis

The typical dose of Revomax depends on the specific infection being treated and the severity of the infection. This combination of Piperacillin and Tazobactam is typically administered through an intravenous (IV) infusion. The recommended dosing schedule is often:

• 2.25 g (2 g Piperacillin + 0.25 g Tazobactam) every 6 to 8 hours in moderate to severe infections.

• Severe infections may require higher doses or more frequent administration.

• The exact dosage and frequency should be determined by the healthcare provider based on the individual patient's condition, kidney function, and the type of infection being treated.

Important: Only a healthcare provider can administer this medication, typically in a hospital or clinical setting.

Common side effects include:

• Nausea or vomiting

• Diarrhea

• Headache

• Skin rash or itching

• Pain at the injection site (if administered IV)

• Elevated liver enzymes (may indicate liver issues)

Serious side effects (though rare) may include:

• Allergic reactions, including anaphylaxis (severe allergic reactions)

• Severe diarrhea (which may indicate Clostridium difficile infection)

• Severe skin reactions, such as blistering or peeling

• Kidney problems, including reduced urine output or swelling in the legs

• Blood disorders, such as low white blood cell count or low platelet count